好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

X + Why: Rethinking the Neurology Residency Curriculum
好色先生, Research, and Methodology
P6 - Poster Session 6 (8:00 AM-9:00 AM)
7-007

To improve outpatient neurology and continuity clinic experiences in a Neurology Residency program by designing an X+Y schedule.

Recent surveys have shown that many neurology residents report inadequate subspecialty exposure, feel unprepared to make fellowship decisions, and experience same-day conflict between inpatient and outpatient rotations. Similar challenges in the field of Internal Medicine (IM) led to the adoption of the X+Y schedule by many IM Residency programs. Increased use of the X+Y schedule by Neurology Residency Programs may help address the current challenges in outpatient neurology education.

The framework for the X+Y neurology curriculum was based on schemas originally created by IM residency programs and included “X” number of inpatient weeks followed by “Y” number of outpatient weeks. Practical considerations included securing enough clinic space, as well as ensuring faculty and ancillary staff availability for clinics to operate successfully.

A 4+1 schedule for PGY2 neurology residents in the 2023-2024 academic year was created and implemented on July 3, 2023. The basic structure included 4 weeks of inpatient service followed by 1 week of ambulatory neurology. The outpatient week incorporated 2 subspecialty clinic days, 2 continuity clinic days at 2 separate sites, as well as 1 administrative day. A pre-intervention survey was sent to PGY2 residents in the 2022-2023 traditional curriculum, which will be compared to post-intervention survey results from PGY2 residents in the 2023-2024 X+Y curriculum.   

The implementation of a 4+1 Neurology Residency schedule is feasible. The X+Y schedule may address challenges in outpatient neurology education by providing increased and earlier outpatient exposure while reducing same-day conflict with inpatient services. Additionally, these changes may improve resident wellness by dividing up long stretches of consecutive inpatient time. Pre and post-intervention surveys will help assess the impact of the X+Y schedule on various aspects of outpatient neurology education.

Authors/Disclosures
Toni Cao, MD
PRESENTER
Dr. Cao has nothing to disclose.
Jasmine L. May, MD, PhD An immediate family member of Dr. May has received personal compensation for serving as an employee of Doximity. An immediate family member of Dr. May has stock in Doximity.
Carolyn J. Bevan, MD (Jesse Brown VAMC) Dr. Bevan has received intellectual property interests from a discovery or technology relating to health care.
Katherine Carroll, MD (Northwestern Department of Neurology) Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie.
Danny Bega, MD (Northwestern University) Dr. Bega has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Healthcare. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Bega has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN / ANA. The institution of Dr. Bega has received research support from Huntington Disease Society of America. The institution of Dr. Bega has received research support from Parkinson Foundation.